1 Min Read
Jan 9 (Reuters) - Tg Therapeutics Inc :
* TG Therapeutics announces Orphan Drug Designation for the combination of TG-1101 and TGR-1202 for treatment of chronic lymphocytic leukemia Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.